CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 95 filers reported holding CTI BIOPHARMA CORP in Q2 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $82,000 | +20.6% | 200 | 0.0% | 0.00% | – |
| Q2 2016 | $68,000 | -35.8% | 200 | 0.0% | 0.00% | – |
| Q1 2016 | $106,000 | -56.9% | 200 | 0.0% | 0.00% | – |
| Q4 2015 | $246,000 | -49.2% | 200 | 0.0% | 0.00% | – |
| Q3 2015 | $484,000 | -59.3% | 200 | -52.7% | 0.00% | – |
| Q2 2015 | $1,189,000 | +228.5% | 423 | +111.5% | 0.00% | – |
| Q1 2015 | $362,000 | -25.2% | 200 | 0.0% | 0.00% | – |
| Q3 2014 | $484,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|